Rayno Life Sciences-Biopharmaceutical Update: Turbo Boost From Vertex (VRTX)
Vertex Pharmaceuticals Gives Biotech Sector A Turbo Boost Vertex (VRTX $82), a laggard in the frothy biotech universe rose an astonishing 58% on positive Phase 2 clinical news from its cystic fibrosis drug VX-661. The study showed statistically significant improvement in lung function among...
Risk Off Resumes After One Day Rally: Caution on QQQ,IBB
Major Sell-Off Early On April 17--Correction is Here with Some Technical Damage Posted 12.15p EDT, Update at 4:56p The rally yesterday was apparently a head fake as a major sell-off resumed today with the NASDAQ down 2.10% and the S&P down 1.7%. The gold free fall on Monday foreshadowed...
Gold Liquidation Is Infecting Equities- Even Biotech With NASDAQ Down 1.6%
Gold Crash Spooks Traders-Life Science Stocks Lose Resilience IBB ($166.82) Down 1.6% Rayno Life Science Stocks- Quick Look With NAZ at 2343 We have not made any Rayno Portfolio changes but have added two stocks recently: Genomic Health (GHDX) and Hologic (HOLX) both down about 1.3% today. The...
Risk Off Day-Retail Sales Disappoint But Life Science and Drug Stocks Hold
Biotech and Drug Stocks Remain in the Sweet Spot NAZ Down 0.16% at 3295 at Close A string of market up days was halted today as retail sales and consumer sentiment gave bearish indicators.Commodity stocks were also weak-energy down 1.2%, materials down 1.7%- and there is a "whiff of deflation"...
Rayno Life Science Winners: EXAS, HOLX,TMO
Life Science Stocks Blow Through New Highs The Rayno Biopharma stocks continued their run today and some Tools/DX stocks are freshening up. Yesterday we added Hologic (HOLX) as a turnaround/value play and it is up 1.73%. Other Rayno winners in this lagging sector today are : Alere (ALR),...